Purinergic P2X Receptor Agonists [purinergní receptory P2X - agonisté]
- Terms
-
purinergní receptory P2X1 - agonisté
purinergní receptory P2X2 - agonisté
purinergní receptory P2X3 - agonisté
purinergní receptory P2X4 - agonisté
purinergní receptory P2X5 - agonisté
purinergní receptory P2X6 - agonisté
purinergní receptory P2X7 - agonisté
purinoceptory P2X - agonisté
-
P2X Purinoceptor Agonists
P2X1 Purinoceptor Agonists
P2X2 Purinoceptor Agonists
P2X3 Purinoceptor Agonists
P2X4 Purinoceptor Agonists
P2X5 Purinoceptor Agonists
P2X6 Purinoceptor Agonists
P2X7 Purinoceptor Agonists
Purinergic P2X1 Receptor Agonists
Purinergic P2X2 Receptor Agonists
Purinergic P2X3 Receptor Agonists
Purinergic P2X4 Receptor Agonists
Purinergic P2X5 Receptor Agonists
Purinergic P2X6 Receptor Agonists
Purinergic P2X7 Receptor Agonists
Compounds that bind to and stimulate PURINERGIC P2X RECEPTORS. Included under this heading are agonists for specific P2X receptor subtypes.
- DUI
- D058911 MeSH Browser
- CUI
- M0545349
- Previous indexing
- Receptors, Purinergic P2/agonists (1994-2010)
- History note
- 2011
- Public note
- 2011
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AN
- analysis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 1
- PD
- pharmacology 3
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UR
- urine 0